Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Researchers from Harbin Veterinary Research Institute report details of new studies and findings in the area of immunization
May 27th, 2009
Investigators publish new data in the report 'In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.' According to a study from Harbin, People's Republic of China, "To study the in vivo evolution of the attenuated Chinese equine infectious anemia virus (EIAV) vaccine, viral gp90 gene variation and virus replication in immunosuppressed hosts were investigated. The results showed that after vaccination, the gp90 gene followed an evolutionary trend of declining diversity." "The trend coincided with the maturation of immunity to EIAV,...
Source: Vaccine Weekly (2009-05-27)
|
